T5	Treat-Disorder 28 38	acromegaly
T7	Effect 73 82	hepatitis
T8	Treatment 118 160;169 203	long-acting somatostatin-analog octreotide GH receptor antagonist pegvisomant
T4	Subject 13 38	a patient with acromegaly
T11	Drug 192 203	pegvisomant
T12	Drug 150 160	octreotide
T10	Severity_cue 53 59	severe
T6	Adverse_event 43 52	developed
T9	Combination 90 108	combined treatment
E1	Adverse_event:T6 
E2	Combination:T9 arg:T11 arg2:T12
A1	Severity E1 High
